Skip to content

Prediction of therapeutic effect for refractory ulcerative colitis by measuring cytokines in colon lesion tissue and blood

Prediction of therapeutic effect for refractory ulcerative colitis by measuring cytokines in colon lesion tissue and blood - Prediction of therapeutic effect for refractory UC by measuring cytokines in colon and blood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000005699
Enrollment
60
Registered
2011-06-01
Start date
2011-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Sponsors

Keio University, School of Medicine Department of Internal Medicine Division of Gastroenterology and Hepatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The objects are patients diagnosed with ulcerative colitis by the diagnostic criteria of Japanese Health, Labour and Welfare Ministry. The purpose and nature of this study are explained to each subject, and written informed consent must be obtained.

Exclusion criteria

Exclusion criteria: Those patients who do not consent to this study.

Design outcomes

Primary

MeasureTime frame
Relaion between cytokines in rectal mucosa and blood and clinical improvement assesed by endoscopic findings and clinical symptoms.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026